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Summary. We study the dynamics of cause–specific mortality rates among countries by consid-
ering them as compositions of functions. We develop a novel framework for such data structure,
with particular attention to functional PCA. The application of this method to a subset of the WHO
mortality database reveals the main modes of variation of cause–specific rates over years for men
and women and enables us to perform clustering in the projected subspace. The results give many
insights of the ongoing trends, only partially explained by past literature, that the considered coun-
tries are undergoing. We are also able to show the different evolution of cause of death undergone
by men and women: for example, we can see that while lung cancer incidence is stabilizing for
men, it is still increasing for women.
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1. Introduction
Overall mortality trends may be partially explained by cause-specific data. A recent example
is provided by Woolf and Schoomaker (2019) who try to shed light on the decreasing trend of
US life expectancy inspecting mortality by cause, finding that midlife mortality caused by drug
overdoses, alcohol abuse, suicides, and a diverse list of organ system diseases have particularly in-
creased in the latest years. However, analyzing trends of cause specific mortality rates (CSMRs)
is not straightforward, as dimensionality of data (rates by cause, year and country) might easily
reach a size difficult to manage. One common solution is reducing dimensionality by collapsing
one or more components: for instance, Canudas-Romo et al. (2020) use TCAL indicator to sum-
marize evolution over time of cause-specific mortality, but in this way it is no longer possible
to explain the time trends. An additional issue when dealing with cause-specific mortality is
the competing risk setting: a cause-specific mortality rate can decline because there has been
a significant improvement in treatment and/or prevention of that disease or just because other
causes have risen meanwhile. Therefore, if we want to analyze the time trend of CSMRs we
need to take into account this feature. One way to do this is by means of Compositional Data
Analysis (CDA) (Aitchinson, 1986; Egozcue and Pawlowsky-Glahn, 2011), which is the study of
compositions, i.e. data where quantities are part of a whole, by their representation as points
on a D–dimensional simplex. Cause-specific mortality rates can be seen as compositional data,
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in the sense that their sum is the overall mortality rate but, if we consider their time trend, we
have not only points in a simplicial space, but curves. Therefore we suggest that CDA might be
combined with elements of Functional Data Analysis (FDA) (Ramsay and Silverman, 2005). For
example, Functional PCA can be applied to reveal what are the main components driving the
latest trends of CSMRs in a selected group of countries. Moreover, countries could be grouped
with respect to the evolution of their CSMRs. Therefore, combining CDA and FDA we analyze
trends of causes of death in 22 countries, which are eventually clustered according their CSMRs’
evolution. The analysis proposed here is essentially descriptive, however it has the advantage of
encompassing all causes of death and, at the same time, allowing to focus on specific causes.
The paper is organized as follows: in the next section we motivate our analysis and describe
the data we used; section 3 describes the way in which FDA and CDA are combined together,
section 4 shows the results and section 5 illustrates the conclusions.
2. Motivations and Data
Cause-specific mortality rates (CSMRs) on calendar year t are derived from all–causes rates mtx
and deaths for each cause i, age x and time t, Di tx. Following Preston et al. (2001), the CSMRs
are defined as
mi tx = m
t
x ·
Di tx
Dtx
, (1)
where Dtx is the number of deaths for all causes occurred at time t and age x. Therefore,
considering that
∑
i D
i t
x = D
t
x we have that
mi tx
mtx
=
Di tx
Dtx
and
∑
i
mi tx
mtx
= 1. (2)
Equation (2) shows that CSMRs are compositional data, conditional to age. Interestingly, Oep-
pen (2008) and Kjærgaard et al. (2019) also use compositional analysis applied to cause-specific
mortality, but with forecasting purposes, which lead them to consider multiple–decrement life
tables deaths di tx rather than rates, as the sum of them over i and x is one (the radix of life
table). So they consider di tx as a composition over causes i and over ages x, and in this way
they only have to make one forecasting step. However, in a descriptive perspective – which is
the one we are taking – mixing cause pattern and age pattern, which are varying across time,
countries and causes, would make interpretation more difficult, so we condition to a specific
age group (40–64) that we consider more important: we excluded younger ages, as the causes
involved in mortality are very limited (especially infant mortality). Ages older than 65 are also
excluded, considering that the leading causes at old ages are fundamentally different from those
in midlife, as also shown by Horiuchi et al. (2003). So we focus on premature mortality cause
of deaths pattern and old age can be analyzed separately.
From (2) it follows that analyzing the ratio between cause-specific deaths ( Di tx) and all-causes
deaths (Dtx) is equivalent to analyze the ratio between cause-specific rates ( m
i t
x) and all-causes
rate (mtx). This brings about the advantage of using a unique source of data: the World Health
Organization (2019) mortality database, which provides data on cause and age specific deaths
for all countries. Should we use also all-causes mortality rates, we would need to turn to an
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Table 1. Countries considered.
Area Countries
North EU Denmark, Finland, Norway, Sweden, Iceland
West EU Austria, Belgium, Switzerland, France, Ireland, Netherlands, UK
South EU Italy, Spain, Greece
Central EU Hungary, Poland
Extra-EU Australia, Canada, Japan, New Zealand, USA
Table 2. Causes of death considered with related International Classification of Diseases (ICD)
codes for each revision.
Cause group ICD–7 ICD–8 ICD–9 ICD–10
Certain infectious
and parasitic dis-
eases (INF)
A001–A043, A104,
A132, B001–B017,
B043
A001–A044 B01–B007 A00-B99
Endocrine, nutri-
tional and metabolic
diseases (END)
A061–A064, B020 A062–A066 B18–B19 E00-E88
Circulatory system
diseases (CIRC)
A070, A079–A086,
B022, B024–B029
A080–A088 B25–B30 I00–I99
Neoplasms (NEOP) A044–A060, B018–
B019
A045–A050,
A052–A061
B08–B09, B100,
B109, B11–B17
C00–C32,
C34–D48
Lung cancer
(LUNG)
A050 A051 B101 C33-C34
Respiratory diseases
(RESP)
A087–A097, B030–
B032
A089–A096 B31–B32 J00-J98
Digestive system dis-
eases (DIG)
A098–A107, B033–
B037
A097–A104 B33–B34 K00–K93
External causes of
death (EXT)
A138–A150, B047–
B050
A138–A150 B47–B56 V00–Y89
additional source (for instance the Human Mortality Database), but given equation (2), Di tx
and Dtx is all we need.
2.1. Data
WHO mortality database is an archive of the causes of death information for several countries.
The longest time series starts in 1950, however for many countries the information is available
only since 1959. We need to consider the same time window for each country, so we focus
on years 1959–2015, and we only consider countries for which data are available in this time
frame. Moreover, we chose countries with relatively high longevity and quality of data, so our
final analysis restricts to countries listed in table 1. An important issue is that classification
of causes of death has greatly changed since 1959, passing from ICD 7th to ICD 10th revision.
Following Canudas-Romo et al. (2020), we therefore use broad classes of causes that are little
affected by changes between different revisions, see table 2. Deaths due to other causes and
infant mortality, not relevant for our analysis, were removed. Note that some adjustments has
been made: for example, HIV has been classified among Endocrine diseases in ICD–9 revision
and moved to Infectious diseases class in revision 10, so we moved it in the INF class also for
revision 9. In addition, we found that in Austria diabete mellitus with circulatory complications
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is classified among endocrine diseases, and we moved it to class CIRC (circulatory diseases)
to make the classification consistent with what have been done for other countries. Then, we
obtained regular curves from noisy data by spline smoothing and finally, since in some years
data are missing for few countries (namely 2005 for Australia, 1997–1998 for Poland, 2000 for
UK and 2015 for New Zealand), we applied the approach suggested by Kraus (2015) to impute
missing parts of the curves.
3. Methodology
As pointed out in the previous sections, CSMRs data can be thought as realizations of random
functions taking values in the D–dimensional simplex and, to the best of our knowledge, there
is no formal treatment of such data in the literature. Petersen and Mller (2016) and Hron
et al. (2016) consider the similar problem of analyzing samples of densities, i.e. functional data
with the additional constraints f(x) ≥ 0 and ∫ f(x)dx = 1 that can be though as continuous
compositions: the density at a specific point x is an infinitesimal part of the density function
and the total contribution of the parts is fixed to 1. The main difference with the present work
is that in our case we consider compositional functional data: discrete compositions where each
part is a function fd(t) and the constraint
∑
d fd(t) = 1 holds for every t on a given interval.
This section aims to furnish the main tools to analyze compositional functional data and, to
do that, we extend the theory in Aitchinson (1986) about standard compositions to deal with our
complex data structure. In particular, computation of the mean function, covariance operator
and principal component analysis is presented in sections 3.1-3.2 while section 3.3 discusses
details about a clustering procedure we applied to data.
3.1. The functional simplex
A functional composition can be defined as a random function f : I ⊂ R→ SD from a subset of
the real line to the D–dimensional simplex. With different terms, a functional composition is a
multivariate random function, f(t) = [f1(t) . . . fD(t)] where each fd : I ⊂ R → R, d = 1, . . . , D
is a function from a subset of the real line to R with the additional constraint that fd(t) ≥
0 ∀d,∀t ∈ I and ∑Dd=1 fd(t) = 1 ∀t ∈ I. We refer to realizations of functional compositions
as compositional functional data. These data enjoy most of the properties of multivariate
functional data but the constraint imposes some important modifications. Aitchinson (1986)
shows that compositional data lie on the simplex which has a different geometry with respect
to RD. Similarly, compositional functional data lie in a function space that we call functional
simplex for which usual operations in L2 cannot be applied. We define the functional simplex
SDf (I) as the collection of all D–variate functions f : I ⊂ R→ SD that satisfy
D∑
d=1
∫
I
[
log
{
fd(t)
f˜(t)
}]2
dt <∞ (3)
where f˜(t) =
[∏D
d=1 fd(t)
]1/D
is the geometric mean of the components of f . The functional
simplex is a separable Hilbert space equipped with vector operations as summation and mul-
tiplication to a scalar. Specifically, the sum of two elements in this space takes the form of a
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perturbation
f ⊕ g = C [f1(t) · g1(t), . . . , fD(t) · gD(t)], (4)
and multiplication to a scalar becomes powering
α f = C [fα1 (t), . . . , fαD(t)], (5)
where C denotes the closure operator, i.e. Cx =
[
x1∑
xi
, . . . , xD∑xi ]. These operations are the nat-
ural extensions of perturbation and powering on the simplex, and their existence is necessary for
the computation of quantities relevant from a statistical point of view. In addition, the geometry
of the space can be defined by its inner product that, for any two functional compositions f
and g, is
〈f , g〉SDf =
D∑
d=1
∫
I
log
{
fd(t)
f˜(t)
}
log
{
gd(t)
g˜(t)
}
dt. (6)
The centered log ratio (clr) transform (Aitchinson, 1986; Egozcue and Pawlowsky-Glahn,
2011) for compositional data is a map between the D–dimensional simplex and RD−1. This
transformation is particularly important since not only establishes an isomorphism between the
two spaces, but it allows to compute quantities on the simplex through operations outside of it.
Here, we define the clr transform for functional compositions. This extension can be though as
the application of the standard clr transform to the composition evaluated at a specific point
t, for every t ∈ I. Let U be the subset of the cartesian product of D copies of L2 defined as
U = {u(t) ∈ LD2 |
∑D
d=1 ud(t) = 0}. The centered log ratio transform for functional compositions
is a function clr : SDf → U ⊂ LD2 from the functional simplex to U defined by
f∗ = clr{f} = log
[
f1(t)
f˜(t)
. . .
fD(t)
f˜(t)
]
, (7)
where f˜(t) is the geometric mean of the components of f . This function maps elements of the
functional simplex into elements of a subspace of LD2 , allowing us to work outside the functional
simplex. To go back to the original space, we use the inverse transform clr−1 : U ⊂ LD2 → SDf
defined by
f = clr−1{f∗} = C {exp[f∗1 (t) . . . f∗D(t)]}. (8)
As an immediate consequence of these definitions we have that the functional simplex is
isomorphic to LD−12 and the inner product defined in (6) is the same as the usual LD2 inner
product between the two clr transformed functions, i.e. 〈f , g〉SDf = 〈f∗, g∗〉LD2 . The clr transform
has the important property that, for any two real constants α and β and any two functional
compositions f and g,
clr{(α f)⊕ (β  g)} = α · clr{f}+ β · clr{g}. (9)
This property is central in the computation of the mean and principal components of com-
positional functional data, since perturbations and powerings on the functional simplex can be
performed by other operations in LD2 .
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3.2. Mean, covariance operator and principal component analysis
We define the expectation of a functional composition as µf = Ef = clr−1{Eclr{f}}. Suppose
to have a sample of compositional functional data {f1(t), . . . ,fn(t)} on a given time interval I
as, for example, trends of CSMRs. The mean function µf on the functional simplex representing
the average trend can be estimated by
µ̂f (t) =
n⊕
i=1
[
1
n
 fi(t)
]
. (10)
Equation 10 consists in perturbations and powerings and, thanks to property (9) we can
compute these quantities only through operations outside the functional simplex:
µ̂f (t) = clr
−1
{
1
n
n∑
i=1
clr{fi(t)}
}
. (11)
Note that the alternative computation of (1/n)
∑n
i=1 fi(t) would lead to an improper esti-
mator of the mean function. In the next section, we will apply estimator (11) to the sample of
countries introduced in section 2.1 in order to depict the average trend of CSMRs.
Next we have to define a valid covariance operator for functional compositions. The definition
of covariance is not straightforward for compositional data: Aitchinson (1986) proposed three
different specifications based on transformations of data. One of them relies on the clr transform
and we follow this specification in our work. Basically, for a composition x each entry of the
covariance matrix R, rjl, is equal to the covariance between the j–th and l–th transformed part
of x, i.e. rij = cov(clr{xj}, clr{xl}). Thus, the covariance operator of a functional composition
can be defined as the integral operator Rf∗ =
∫
r(s, t)f∗(t)dt where r(s, t) is a D × D block
kernel such that for block {j, l}
rjl(s, t) = E
{
clr{fj(s)} · clr{fl(t)}
}
= E
{
log
(
fj(s)
f˜(s)
)
· log
(
fl(t)
f˜(t)
)}
, (12)
where for simplicity we assume Ef∗ = 0. Similarly to the scalar case, the covariance kernel
r(s, t) is singular in the sense that satisfies the conditions
∑J
j=1 rjl(s, t) =
∑L
l=1 rjl(s, t) = 0.
However it is still positive–definite and admits the decomposition
r(s, t) =
∞∑
k=1
λkφ
∗
k(s)φ
∗
k(t), (13)
where {λ1, λ2, . . .} ∈ R are the eigenvalues and {φ∗1,φ∗2, . . .} ∈ U are the eigenfunctions of the
covariance operator R. Since the eigenfunctions of the covariance operator R constitute an
orthonormal basis for U , their compositional counterparts {φ1,φ2, . . .} obtained through the
function clr−1 are an orthonormal basis in the functional simplex. Finally, as a consequence of
the Karhunen–Love theorem, we can represent every functional composition as
f 	 µf =
∞⊕
k=1
[
ξk  φk(t)
]
, (14)
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where {φ1,φ2, . . .} ∈ SDf are transformed eigenfunctions, i.e. φk = clr−1{φ∗k} ∀k and {ξ1, ξ2, . . .} ∈
R are computed as ξk = 〈f ,φk〉SDf . Again, for (9) we have that
f(t) = clr−1
{
clr{µf (t)}+
∞∑
k=1
ξkclr{φk(t)}
}
. (15)
Given a finite sample of compositional functional data {f1(t), . . . ,fn(t)}, the estimation of
each block of the covariance kernel can be done through
r̂jl(s, t) =
1
n
n∑
i=1
{
log
(
fij(s)
f˜i(s)
)
· log
(
fil(t)
f˜i(t)
)}
, (16)
where fij(t) and fil(t) are the j–th and l–th part of the i–th observed function minus the sample
mean. The eigenfunctions of the covariance operator R can be computed as the solution of the
system of equations
∫
r(s, t)f∗(t)dt = λf∗(t), as shown in Ramsay and Silverman (2005). From
a practical point of view, one has to compute empirical eigenfunctions {φ̂∗1, φ̂∗2, . . .} using the
covariance kernel r̂(s, t) estimated from data, solving the problem∫
r̂(s, t)f∗(t)dt = λf∗(t), (17)
then, transformed eigenfunctions can be obtained as φ̂k = clr
−1{φ̂∗k}.
Computation of the empirical eigenfunctions is important because the result provides in-
formation about the main modes of variation in the considered sample. For complex data as
CSMRs over time, these functions represents a straightworward way to inspect the simultaneous
directions of variability of all causes of death. The empirical scores {ξ̂i1, ξ̂i2, . . .} for the i–th
observation fi can be computed as
ξ̂ik = 〈f∗i ,φ∗k〉 =
∫
clr{fi}(t)φ∗k(t)dt. (18)
Finally, by truncating the infinite series in (15) and replacing population quantities with
estimates, one obtains the approximation
f(t) ' clr−1
{
clr{µ̂f (t)}+
K∑
k=1
ξ̂kclr{φ̂k(t)}
}
. (19)
This representation is particularly useful because it gives an approximation of a functional
composition using few nonrandom functions shared among observations and few scalar random
variables, thus reducing the problem to a finite–dimensional one. The relevance in our appli-
cation is that CSMRs observations can be summarized by their behaviour with respect to few
main modes of variation. The projections on the finite–dimensional space can also serve as a
basis for a clustering procedure, as explained in the next subsection.
3.3. The Clustering Step
A common practice in FDA is to reduce the dimensionality of data and use projections on a finite
dimensional space as a starting point for other procedures, such as clustering or classification
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(see for instance Leng and Mller (2006); Sangalli et al. (2009)). In our context, the compositional
functional PCA allows us to drastically reduce the complexity of CSMRs over time by considering
only few components, accounting for most of the variability in the sample. Then, in order to
detect a clustering structure, one possibility is to apply a procedure for euclidean data to the
scores of our original compositional functional data.
Spectral clustering (see von Luxburg (2007) for an overview) is a relatively recent clustering
method. It is based on the eigenanalysis of the Laplacian matrix constructed on the similarity
graph of the data. Its advantage over alternative procedures is the ability to detect complex and
nonlinear structures. The application of this method to our context needs no further adjustments
with respect to the original formulation, but we have to choose some parameters. In particular,
we set the gaussian similarity kernel defined as s(ξi, ξj) = exp(−‖(ξi − ξj‖2 /(2σ2)) with σ = 1
as kernel to compute the similarity graph among scores, and k–means (Izenman, 2008) as base
method. The output of the clustering procedure is given by a set of G centroids γ1, . . . ,γG
and a vector of labels of cluster membership. Since the method is sensible to initialization,
we run spectral clustering algorithm for B times and compute the majority vote as the most
frequent partition of data over B repetitions. For this method, the decay of the spectrum of
the Laplacian matrix can be informative about the number of clusters. However, we did not
observe a clear signal when we applied the method to CSMRs data. Thus we decided to use the
silhouette index for determining the number of clusters, defined as the average of all silhouette
values s(i),
s(i) =
b(i)− a(i)
max{a(i), b(i)} , (20)
b(i) = min
k 6=i
1
|Ck|
∑
j∈Ck
(ξi − ξk)2, a(i) = 1|Ci| − 1
∑
j∈Ci,i 6=j
(ξi − ξj)2, (21)
where ξi is the vector of scores for the i–th observation and |Ck| is the cardinality of the k–th
cluster (Izenman, 2008). The silhouette index ranges from -1 to 1 and higher values correspond
to better cluster configurations.
4. Results
In this section we present the results of the analysis on the WHO mortality database separately
for men and women. We first compute the compositional functional mean as in (11), then we
estimate the covariance kernel using (16) and compute principal components and scores with
(17) and (18). Finally, we apply spectral clustering to the scores in order to obtain a grouping
structure of the countries in the study. The silhouette values for each country are reported in
table 1 of the supplementary material.
4.1. Men
The 22 curves of the men sample for 8 causes of death we consider are given in figure 1. We
depict with a larger colored line the compositional functional mean. The ranges among causes
are different, denoting a different contribution on the total mortality rate. Highest ranges are
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Fig. 1. Composition of mortality rates over years for men population. Curves for 22 countries in each
panel are colored in grey. Colored curves represent the compositional functional mean.
for circulatory diseases (0.20–0.50) and neoplasms (0.10–0.40), representing the two most im-
portant causes of death from 1959 to 2015. However, dynamics are quite different among all
causes: neoplasms and lung cancer in particular exhibit an increasing trend over years, while
circulatory diseases constantly decrease their contribution. A slightly increasing trend can be
noticed also for endocrine, metabolic and nutritional diseases and external causes while respira-
tory and digestive diseases show heterogeneous patterns: some countries have a declining trend,
others an increasing one. Infectious diseases experienced a particular behavior over years: they
diminish their contribution at the beginning of the period, then started to increase and finally
stabilized around a value of 0.02. These results are in line with the epidemiological transition
theory with increasing prevalence of diseases associated with aging (e.g., neoplasms) and of
man-made diseases (lung cancer caused by smoking, metabolic and nutritional disorders, caused
by obesity and external causes of deaths) and a decline of infectious diseases.
The first compositional functional principal component for men population is depicted in
figure 2. This function is computed as described in section 3.2 and represents the main mode of
variation of the men sample. The eigenvalue associated with this eigenfunction is λ1 = 17.06 and
the Fraction of Explained Variance (FEV) is λ1/
∑
λk = 0.337, thus this component account for
about one third of the total variability. This component is related to all causes but respiratory
diseases. A variability connected with the level of the cause – values always above or below the
mean – is present in digestive diseases. For infectious and endocrine diseases, as we already
noticed, the main variability is related only to specific years – 1959-1985 for the former and
1985-2015 for the latter – and we call this aspect local level variability. This behaviour can be
partially observed for circulatory diseases and external causes too. Lastly, a more structured
10 M. Stefanucci and S. Mazzuco
INF
1970 1985 2000 20150
.0
0
0.
05
0.
10
0.
15
++++++++++++++++++++++++++++++
+++++
++++++++++++++++++++++
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−−−−−−
−−
−−
−−−−−−−−−−
−−−−−−−−−−−−
NEOP
1970 1985 2000 20150
.1
0
0.
20
0.
30
0.
40
++++++++++++++++++
++++
+++
++
++
++
++
++
++
+++
+++
++++
++++
++++++
−−−−−
−−−−−−−−
−−
−−
−−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−−
−−
−
−
−
−
−−
−−
LUNG
1970 1985 2000 20150
.0
0
0.
05
0.
10
0.
15
0.
20
++++++++
+++++
++++
++++
++++++
++++++++++++++++++++++++++++++
−−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−−
−−
−−
−
−
−−
−−
−−
−−−−−−−−−
END
1970 1985 2000 20150
.0
0
0.
02
0.
04
0.
06
0.
08
+++++++++
++++++++++++
+++++
+++
+++
+++
+++
+++
++++++
++++++++++
−−−
−
−
−
−
−
−
−
−−
−−
−−
−−−
−−−−−
−−−−−−−−−
−−
−
−−
−
−
−
−
−
−
−
−
−
−
−−
−−
−−
−−−
CIRC
1970 1985 2000 2015
0.
2
0.
3
0.
4
0.
5
0.
6
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++
−−−
−−−−
−−−−
−−−−−−−−−−−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−
−−−−−−−−
RESP
1970 1985 2000 20150
.0
0
0.
05
0.
10
0.
15
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++
−−−−−−−
−
−
−
−−
−
−
−
−
−
−
−
−
−
−
−
−−−−−
−−−−−−−−−−−−−−−−−−−
−−
−−
−−−
−−−
DIG
1970 1985 2000 20150
.0
0
0.
05
0.
10
0.
15
0.
20
++++++++++++++++++++++++++++++++++
+++++
+++++
++++++
+++++++
−−−−−−−−−−−−
−−−
−−−−−−−−−−−−−−−−−−−
−−−−−−
−−
−−
−−−−
−−−−−−−−−
EXT
1970 1985 2000 20150
.0
0
0.
10
0.
20
0.
30
+++++++++++++++++++++++++++++++
++++++
+++++
++++
++++
++++++
+
−−−−
−−
−
−
−
−
−
−
−−
−−−−−−−−−−−−−−−−
−−
−−
−−
−−
−−
−−
−−−−−−−−−−−−−−−
Fig. 2. First compositional functional principal component for men population. The continuous line
represents the mean function while outer lines represent the mean function +/- the component.
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Fig. 3. Second compositional functional principal component for men population. The continuous line
represents the mean function while outer lines represent the mean function +/- the component.
pattern can be seen for neoplasms and lung cancer: for these causes the first compositional
functional principal component crosses the mean at some point. This reflects the fact that in
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Fig. 4. Third compositional functional principal component for men population. The continuous line
represents the mean function while outer lines represent the mean function +/- the component.
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Fig. 5. Fourth compositional functional principal component for men population. The continuous line
represents the mean function while outer lines represent the mean function +/- the component.
our sample some countries had a faster increase of this causes with respect to the mean while
others had a slower increase than the mean. Overall, a positive score on this component would
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lead to a high level of circulatory diseases and endocrine diseases (only after 1985), a low level
of digestive diseases and infectious diseases (only before 1985), a fast increase of neoplasms and
a slow increase of lung cancer. Negative scores characterize an opposite behaviour. The scores
obtained by each country on the first 4 PCs for men sample are reported in table 3.
Figure 3 shows the second compositional functional principal component for men popula-
tion. The eigenvalue associated with this eigenfunction is λ2 = 10.92 and the FEV is 0.216.
This component represents a level variability for neoplasms, circulatory and endocrine diseases,
especially in the last 30 years. Local variability is observed for infectious diseases – note that
the time interval connected with this component is 1985-2015 – and for respiratory diseases,
but to a lesser extent. For lung cancer, digestive diseases and external causes this component
shows a cross–mean behaviour, reflecting different velocities among countries in the evolution
of these contributions. Overall, a positive score on this component would lead to a high level of
circulatory diseases, a low level of neoplasms and endocrine diseases, a fast decay of infectious
diseases, a slow increase of lung cancer and an increase of digestive diseases after 2000.
The third compositional functional principal component for men population is illustrated
in figure 4. The eigenvalue associated with this eigenfunction is λ3 = 7.27 and the FEV is
0.144. This component is mostly connected with four causes of death. It represents a level
variability for lung cancer, respiratory diseases and external causes while local variability is
observed for circulatory diseases, in relation to the period 1959-1990. Overall, a positive score
on this component would lead to a low level of lung cancer and respiratory diseases and to a high
level of external causes and circuatory diseases – especially at the beginning of the considered
period.
Figure 5 depicts the fourth compositional functional principal component for men population.
The eigenvalue associated with this eigenfunction is λ4 = 4.62 and the FEV is 0.091. Also this
component refers to only four causes of death. It represents a level variability for neoplasms
and a local variaility for lung cancer (1959-1995), endocrine diseases (after 2000) and digestive
diseases (from 1970). Overall, a positive score on this component would lead to a low level
of neoplasms and a high level of lung cancer, endocrine diseases and digestive diseases in the
aforementioned periods.
A clustering procedure has been applied to the men sample as described in section 3.3. We
considered the first 4 PCs, accounting for 78.7% of the total variability. For different values
of G, we ran the spectral clustering algorithm for B = 1000 times and save the result of
the majority vote . The spectrum of the Laplacian matrix shows no evidence for a particular
number of clusters, while the silhouette index is maximized for G = 5 clusters, which are
reported in table 4. A visual representation of the scores of the first two PCs along with the
clustering structure can be found in figure 6. Using (19) with K = 4 and γ1g, γ2g, γ3g, γ4g as
the centroids of the spectral clustering output, we reconstructed the compositional functional
centroids fg, g = 1, . . . , G, depicted in figure 7. These trajectories summarize the behavior of
each cluster with respect to the eight causes of death.
We can draw some comments. The first group (including USA, Canada, Australia, New
Zealand, Netherlands and Denmark) is characterized by relatively low circulatory related deaths
(but at the beginning of the observation period it was high) a decreasing trend of lung cancer and
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Table 3. Scores of the 22 countries in the study. Men sample is reported on the left and women sample
on the right.
Countries PC1 PC2 PC3 PC4
AUS 4.38 -2.08 0.32 0.28
AUT -3.83 -1.03 0.95 3.90
BEL 0.44 1.43 -3.02 -0.21
CAN 3.26 -3.80 0.80 0.75
DNK 3.41 -1.51 0.23 3.42
FIN -0.63 6.34 3.59 3.36
FRA -5.20 -3.66 -0.10 0.18
GRE -2.90 1.77 -2.14 -2.28
HUN -5.80 4.11 0.09 3.32
ICE 3.01 3.13 4.77 -3.32
IRL 2.15 4.72 -2.67 -2.63
ITA -2.49 -3.81 -2.90 0.64
JPN -6.76 -2.10 2.89 -2.98
NL 5.55 -1.00 -2.77 0.72
NZL 6.49 -0.69 0.82 -2.21
NOR 2.47 0.72 2.93 -1.17
POL -5.27 3.93 0.19 -1.58
SPA -5.76 -2.51 -3.61 -2.02
SWE 1.37 -1.45 4.52 0.43
SWI -0.65 -2.19 0.55 0.06
UK 4.28 4.84 -5.20 1.05
USA 2.50 -5.16 -0.24 0.27
Countries PC1 PC2 PC3 PC4
AUS 3.08 1.87 0.86 -0.42
AUT -2.76 1.02 -1.31 -3.53
BEL -1.67 2.06 -0.51 -0.01
CAN 2.74 3.76 0.17 -0.37
DNK 4.12 1.92 -2.26 -3.47
FIN -3.01 -2.79 -3.92 0.06
FRA -6.77 2.70 -2.35 0.90
GRE -0.52 -2.37 2.50 0.72
HUN -2.96 -3.25 -1.79 -5.40
ICE 5.40 0.21 -4.05 4.43
IRL 4.00 -5.82 1.25 1.01
ITA -3.72 1.75 4.19 -1.47
JPN -4.21 -1.69 -0.99 4.99
NL 1.98 2.59 0.75 -1.22
NZL 5.10 -0.62 3.00 0.59
NOR 2.37 -0.71 -1.49 1.85
POL -3.63 -4.13 1.14 -0.74
SPA -5.71 -0.81 4.00 1.87
SWE 1.02 1.40 -2.02 0.17
SWI -2.54 2.31 -1.56 0.81
UK 5.97 -3.21 0.61 -2.05
USA 1.73 3.82 3.76 1.29
Table 4. Clustering output for men sample.
Clusters Countries
Cluster 1 USA, Canada, Australia, New Zealand, Denmark, Netherlands
Cluster 2 Italy, France, Spain, Austria, Switzerland, Japan
Cluster 3 Hungary, Poland, Finland, Greece
Cluster 4 UK, Ireland, Belgium
Cluster 5 Norway, Sweden, Iceland
an almost plateauing trend of neoplasms. Notably the level of endocrine and metabolic related
deaths is much higher than other clusters, with a particularly high slope between 1980 and 2000.
This trend is close to that of obesity prevalence in USA, as shown, for example by Fryar et al.
(2014), and New Zealand and Australia show similar figures, so it is likely that this is the leading
cause. It should also be noted that external causes of death are rapidly increasing in the last
years, in line with what is shown by Woolf and Schoomaker (2019). The second group consists
of Italy, Spain, France, Japan, Austria and Switzerland, and is characterized by high lung cancer
mortality – in all countries smoking prevalence is high among men, see for instance, Brennan
and Bray (2002) – and low circulatory-related deaths. At the beginning of the observation period
up to 1980, this group had particularly high level of digestive system diseases and infectious
related deaths, as for most of them the epidemiological transition started later than in other
countries. Third group is made up of Hungary, Poland, Finland and Greece. The main feature
of this group is the increasing relevance of digestive system diseases related deaths. This might
be driven by rising alcohol–attributable diseases, considering that such health problems are a
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Fig. 6. Scores ξ1 and ξ2 for countries in the sample. Different colors represent different clusters.
Table 5. Clustering output for women sample.
Clusters Countries
Cluster 1 USA, Canada, Australia, Denmark, Netherlands
Cluster 2 Italy, Spain, Japan
Cluster 3 France, Switzerland, Belgium
Cluster 4 Hungary, Poland, Austria, Finland, Greece
Cluster 5 UK, Ireland, New Zealand
Cluster 6 Norway, Sweden, Iceland
growing concern in these countries. It must be noted that this is the least homogeneous group,
as can be seen from table 1 of the supplementary material. Finland, for example, has a peculiar
pattern with an extremely high incidence of external causes of deaths that is more consistent
with the group including Sweden, Norway and Iceland but, at the same time, a rapidly increasing
prevalence of digestive diseases that matches more with Eastern Europe group. Greece, instead
is in between cluster 3 and 2 having a particularly high incidence of lung cancer (as in cluster
2) but also a high level – and very slowly declining – of circulatory diseases related deaths, as
in cluster 3. The fourth group is made up of UK, Ireland and Belgium, characterized by high
– albeit descending – levels of lung cancer, respiratory diseases and circulatory diseases and
increasing relevance of digestive system diseases. This might be brought about by risk factors
like smoking, alcohol consumption and poor diet. The last cluster includes Sweden, Norway
and Iceland, characterized by the lowest level of lung cancer and respiratory diseases and the
highest level of external causes.
4.2. Women
The 22 curves of the women sample for 8 causes of death we consider are represented in figure 8.
Similarly to men population, the ranges among causes are different. Highest ranges are observed
for circulatory diseases (0.1–0.4), neoplasms (0.3–0.6) and lung cancer (0.02–0.2). With respect
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Fig. 7. Functional centroids of the spectral clustering for men sample. Legend: —- Cluster 1, —- Cluster
2, —- Cluster 3, —- Cluster 4, —- Cluster 5.
to men, women have a higher contribution of neoplasms and a lower contribution of circulatory
diseases, though trends over years are similar: the former moved from 0.38 to 0.48 and the
latter reduced from 0.4 to below 0.2. Lung cancer had almost negligible contribution at the
beginning of the considered period but, thanks to a strong and constant increase, it is nowadays
as important as in men (slight above 0.1). On the other side, the positive trend for other
neoplasms seems to have reached a plateau since the last decade of the twentieth century. An
opposite behaviour can be found in men, where lung cancer had a stable contribution since
1985 while other neoplasms are still increasing. Another difference can be found for endocrine
diseases, where women do not show an increasing trend. Lastly, infectious diseases experienced
a similar evolution for both men and women.
The first compositional functional principal component for women population is shown in
figure 9. It represents the main mode of variation of the women sample. The eigenvalue
associated with this eigenfunction is λ1 = 14.87 and the Fraction of Explained Variance (FEV)
is λ1/
∑
λk = 0.326, thus, similarly to men, this component accounts for about one third of
total variability. Surprisingly, this component is related to all causes but circulatory diseases,
one of the main causes of death. A level variability can be found for lung cancer, respiratory
and digestive diseases. Similarly for men, local variability is present in infectious and endocrine
diseases, linked to time periods 1959-1985 for the former and 1959-1990 for the latter, but for
the women sample we observe local variability also for external causes, in the interval 1980-2005.
Lastly, neoplasms exhibit a variability pattern related to the velocity of the evolution of this
cause. Overall, a positive score on this component would lead to a high level of lung cancer and
respiratory diseases, a low level of digestive diseases, infectious diseases (especially before 1985),
16 M. Stefanucci and S. Mazzuco
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Fig. 8. Composition of mortality rates over years for women population. Curves for 22 countries in each
panel are colored in grey. Colored curves represent the compositional functional mean.
endocrine diseases (only before 1990) and external causes (between 1980 and 2005) and slow
increase of neoplasms. Negative scores characterize an opposite behaviour. The scores obtained
by each country on each component for women sample are reported in table 3. The second
compositional functional principal component for women population is depicted in figure 10.
The eigenvalue associated with this eigenfunction is λ2 = 7.38 and the FEV is 0.162. This second
component is related to all causes of death. Circulatory and endocrine diseases and external
causes show a level variability. A local variability can be observed for neoplasms (1959-2000),
lung cancer (1980-2015) and respiratory diseases (1959-1995). Lastly, a crossing-mean pattern
can be found in infectious and digestive diseases. Overall, a positive score on this component
would lead to a low level of circulatory diseases and respiratory diseases (before 1995), a high
level of endocrine diseases, external causes, lung cancer (since 1980) and neoplasms (until 2000),
and a increase of infectious diseases after 1985.
Figure 11 shows the third compositional functional principal component for women popula-
tion. The eigenvalue associated with this eigenfunction is λ3 = 5.94 and the FEV is 0.13. This
component represents a level variability for endocrine, circulatory and respiratory diseases and
for external causes and a local variability for neoplasms (before 1990) and lung cancer (after
1990). Overall, a positive score on this component would lead to a high level of endocrine, cir-
culatory and respiratory diseases, a low level of external causes, a low level of neoplasms before
1990 and a low level of lung cancer after 1990.
The fourth compositional functional principal component for women population is illustrated
in figure 12. The eigenvalue associated with this eigenfunction is λ4 = 5.66 and the FEV is 0.124.
This component represents mainly local and most recent variability. In particular it is related
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Fig. 9. First compositional functional principal component for women population. The continuous line
represents the mean function while outer lines represent the mean function +/- the component.
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Fig. 10. Second compositional functional principal component for women population. The continuous
line represents the mean function while outer lines represent the mean function +/- the component.
to neoplasms after 1980, lung cancer and endocrine diseases after 2000, digestive diseases after
1970 and external causes after 1990. Overall, a positive score on this component would lead to
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Fig. 11. Third compositional functional principal component for women population. The continuous line
represents the mean function while outer lines represent the mean function +/- the component.
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Fig. 12. Fourth compositional functional principal component for women population. The continuous
line represents the mean function while outer lines represent the mean function +/- the component.
a high level of neoplasms and external causes and a low level of lung cancer and digestive
diseases, all in the aforementioned periods. As for men, we applied spectral clustering to the
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Fig. 13. Functional centroids of the spectral clustering for women sample. Legend: —- Cluster 1, —-
Cluster 2, —- Cluster 3 —- Cluster 4, —- Cluster 5, —- Cluster 6.
women curves projected on the first 4 PCs. The percentage of total explained variability is
74.2%. The algorithm ran B = 1000 times and we considered different values for G. Again, the
spectrum of the Laplacian matrix does not support any specific number of clusters, while the
silhouette index suggests a value between 6 and 8. For parsimony and interpretability reasons,
we choose to use G = 6 clusters that we present in table 5 (see also figure 6). Using (19) with
K = 4 and γ1g, γ2g, γ3g, γ4g as the centroids of the spectral clustering output, we reconstructed
the compositional functional centroids fg, g = 1, . . . , G, depicted in figure 13.
The first group of countries is similar to that of men: it is mainly made up of extra-European
countries together with Denmark and Netherlands, with a rising trend of lung cancer and respi-
ratory diseases and endocrine and metabolic diseases, related to increasing prevalence of smoking
and obesity among women. The fact that Denmark and Netherlands have been clustered in this
group is not surprising, as it is well-known they have undergone a stagnation of life expectancy
improvement, and smoking is one of the leading causes of this, as shown also by Lindahl-Jacobsen
et al. (2016). The second group is made up by Japan, Italy and Spain, with the lowest level of
lung cancer, in contrast to what has been seen for men in the same countries. Indeed, smoking
prevalence of women in these countries is much lower than that of men, see Brennan and Bray
(2002). The third group includes France, Belgium and Switzerland; the main feature of this
group is the high level of external causes deaths, only recently getting lower than that of Scan-
dinavian countries. The fourth group (which for men includes Hungary, Poland, Greece, and
Finland) now includes also Austria and, as for men, it is characterised by high level of digestive
system diseases related deaths. It should be noted that also for women this is the least homo-
geneous group. Austria, in particular, has a peculiar pattern with a recently increasing trend
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of endocrine and metabolic diseases and a steady level of external causes related deaths. The
group with UK and Ireland now includes also New Zealand, instead of Belgium, but the char-
acteristics are similar to the analogous group for men: high respiratory and circulatory diseases
and increasing digestive system diseases related deaths. Finally, the Scandinavian group: as for
men, the main feature is the high mortality for external causes but, in contrast with men, this
group is also characterized by a high and increasing relevance of lung cancer related mortality.
5. Conclusions
We have proposed to combine compositional data analysis (CDA) and functional data analysis
(FDA) to describe the global trend of cause–specific mortality of several countries. CDA al-
lows us to analyze cause–specific mortality rates (CSMRs) taking properly into account their
competing—risk nature and FDA is then applied to compositional data so that their trends
can be decomposed by means of Functional principal components analysis and countries can be
clustered by means of PCs we have retrieved. In this way we are able to make a descriptive but
comprehensive analysis of trends of CSMRs. Results give us many insights of the ongoing trend
that the considered populations are undergoing in terms of composition of causes of deaths and,
while many of them come as no surprise, in some cases we find some evidence that has not been
highlighted by past literature. We should bear in mind that our analysis is focused on ages
40–64, so all considerations should be applied to mid-life mortality only.
The first finding is that clusters for men and women are very similar, albeit some differences
can be found: the main one is that for women we have one cluster more, which is basically the
result of splitting the cluster 2 into two. However, even though the clustering results are quite
similar for men and women, we can easily notice that evolution of mortality composition is quite
different: in all countries, prevalence of lung cancer among men has stopped increasing between
1990 and 2000, while for women it kept on rising until the very recent years, when first signs
of plateauing can be seen. Moreover for some countries we can see a high disparity between
men and women (e.g., Italy, Japan and Spain are in the cluster with lowest level of lung cancer
for women and in that with the highest for men, while for cluster including Nordic countries
is the other way round) while for others (e.g., East European countries) women catch up with
men. Relevance of digestive system and metabolic, endocrine and nutritional diseases related
deaths is increasing especially for men, suggesting that poor dieting and alcohol consumption
are increasingly impacting on men’s health. For women a rising concern is lung cancer and
respiratory diseases, especially in Nordic countries. Interestingly some countries have a peculiar
pattern that is difficult to group with others. Finland, in particular, with extremely high exter-
nal causes and digestive system diseases related deaths, shows a composition of causes of death
that is difficult to classify. Such peculiarity is confirmed by the relatively low life expectancy
with respect to other Scandinavian countries.
Although FDA and CDA approaches are helpful in explaining cause–specific mortality trends
in a comprehensive way, both of them come with a specific limitation. The limitation of FDA is
that it allows a descriptive analysis through functional principal components and cluster anal-
ysis, but it can not be used in a straightforward way to forecast the future trends. A forecast
application that takes into account the compositional aspect but not the functional one has
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been implemented by Kjærgaard et al. (2019). The limitation of CDA is that it focus on cause–
specific rates, but the overall trend is not considered. However, the clusters we identified largely
capture differences in overall mortality rate trends of countries.
On the other hand, such a combination of CDA and FDA can be helpful in other applications:
the same analysis can be applied to older ages (65+), where, following Horiuchi et al. (2003), we
can expect to find higher prevalence of infectious diseases, mental disorders and cerebrovascular
diseases. Another possible application, remaining in the demographic field but turning to a
different aspect, could be to describe trends of parity–specific fertility rates, which can be seen
as a composition of the overall fertility, although it could be hard to find a sufficient number of
countries with parity–specific fertility data for a long enough time window.
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